Hellenic Cardiovascular Research Society Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2014
NCT02071212
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

clopidogrel (plavix) (1 trial)

ticagrelor (brilinta) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 2)

Coronary Disease (Phase 2)

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 2)

ST Elevation Myocardial Infarction (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2